In a report published Wednesday, Bank of America analyst Sara Gubins reiterated a Buy rating and $137.00 price target on Towers Watson & Co. TW.
In the report, Bank of America noted, “We forecast mid-single-digit revenue growth over the medium-term along with 30-40bp of margin expansion per year. Towers Watson is the leader in the Medicare-eligible employer-sponsored private health care exchange market and is seeking to expand into other health care ex changes for active employees. This is an area of significant growth potential, in our view.”
Towers Watson & Co. closed on Tuesday at $105.80.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in